In silico evaluation of antimalarial compounds derived from the stem bark of Senegalia polyacantha (Willd.) Seigler & Ebinger (Fabaceae) against the validated target: Plasmodium falciparum prolyl-tRNA synthetase
Our previous preliminary in vitro studies indicated that extracts and isolated compounds ( 1 – 24 ) from the stem bark of Senegalia polyacantha ( S . polyacantha ) exhibit antimalarial properties associated with cytotoxicity profiles that are suitable for subsequent in vivo investigations in animal models. Advancing these in vivo studies, however, requires prior insight into the potential mechanism of action of the plant’s major chemical constituents. In this context, the present study was undertaken to assess the stability of chemical compounds isolated from the trunk bark of S. polyacantha against a validated therapeutic target for malaria. Twenty-four compounds ( 1 – 24 ) previously shown to be active against chloroquine-sensitive and multidrug-resistant strains of Plasmodium falciparum ( P . falciparum ) were subjected to molecular docking using Maestro-13.9 against P. falciparum prolyl- t RNA synthetase ( Pf cProRS) (PDB ID: 7QC1). Their molecular dynamics (MD) were subsequently evaluated in GROMACS over 0.1 ns, 5 ns, and 110 ns to predict the most stable hits. Molecular docking on Pf cProRS suggested that hits 6 – 10 , 14 , and 17 – 24 could interact favourably with the target (S <− 7 kcal/mol). During the 0.1 ns of simulation, hits 6 – 8 , 10 , and 22 were unstable (RMSD > 2 Å). At 5 ns, compounds 9 , 19 , and 23 also showed instability (RMSD > 3 Å). In silico cross-reactivity analysis shows that compounds 14 , 17 , 20 – 21 , and 24 interact strongly with the Halofuginone binding site on Homo sapiens ( Hs )ProRS, revealing a lack of clear selectivity at the initial docking level. Overall, these findings highlight compounds 14 , 17 , 20 – 21 , and 24 as the most promising hits for rational structural optimization to engineer parasite-specific selectivity, and provide a theoretical rationale to support subsequent in vitro Pf ProRS enzyme inhibition assays compared to Hs ProRS, then in vivo studies to further assess their safety and therapeutic potential against malaria.
Authors
- Peron Bosco Leutcha (ORCID: https://orcid.org/0000-0003-4268-3746)
- Hermann Fomena
- Alain Méli Lannang (ORCID: https://orcid.org/0000-0001-5422-0357)
- Mireille Laura Wondja Ngoko
- Maminata Traoré‐Coulibaly (ORCID: https://orcid.org/0000-0002-0519-4727)
- Yves Oscar Nganso Ditchou (ORCID: https://orcid.org/0000-0001-7081-1093)
- Gabrielle Ange Amang à Ngnoung
- Relwendé Justin Ouédraogo (ORCID: https://orcid.org/0000-0002-5036-2144)
- Noufou OUEDRAOGO
- Lassina Ouattara
- Flore Judith Tchuissang Mbougnia
- Hamadou Mamoudou
- Elvira Erika Feuwoue Tchokotcheu
Institutions
- Université de Yaoundé I (CM)
- University of Douala (CM)
- University of Maroua (CM)
- Nazi Boni University (BF)
- Centre National de la Recherche Scientifique et Technologique (BF)
- Institut de Recherche en Sciences de la Santé (BF)
- Université d’Ébolowa (CM)
- University of Ngaoundéré (CM)
- Muğla University (TR)
Publication Details
- Journal
- In Silico Pharmacology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1007/s40203-026-00797-z
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00